Takeda expands in Brazil with Multilab buy
This article was originally published in Scrip
Executive Summary
Takeda has agreed to pay up to Real540 million ($270 million) for the Brazilian company Multilab Indústria e Comércio de Produtos Farmacêuticos, expanding its reach in an important emerging market and also into the branded generics segment in the country.
You may also be interested in...
Quick Listen: Scrip’s Five Must-Know Things
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
PMDA Eyes More Japan-First Approvals In Access Push
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Quick Listen: Scrip’s Five Must-Know Things
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.
Need a specific report? 1000+ reports available
Buy Reports